SPRC Stock Summary and Trading Ideas (Scisparc Ltd. - | NASDAQ:SPRC)

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Scisparc Ltd. - trades on the NASDAQ stock market under the symbol SPRC.

As of June 29, 2026, SPRC stock price declined to $5.61 with 297,363 million shares trading.

SPRC has a beta of 3.02, meaning it tends to be more sensitive to market movements. SPRC has a correlation of 0.04 to the broad based SPY ETF.

SPRC has a market cap of $3.17 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, SPRC traded as high as $2,997.01 and as low as $2.98.

SPRC has underperformed the market in the last year with a price return of -90.3% while the SPY ETF gained +22.3%. However, in the short term, SPRC had mixed performance relative to the market. It has outperformed in the last 3 months, returning +40.3% vs +15.2% return in SPY. But in the last 2 weeks, SPRC shares have been beat by the market, returning -34.4% compared to an SPY return of +0.2%.

SPRC support price is $5.02 and resistance is $6.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SPRC shares will trade within this expected range on the day.